All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition
During the Virtual 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the Lymphoma Hub spoke to Mehdi Hamadani, Medical College of Wisconsin, Milwaukee, US. We asked, What are the options for cell-based therapies in mantle cell lymphoma?
What are the options for cell-based therapies in mantle cell lymphoma?
In this video, Hamadani gives an overview of the three main cell-based therapy options for mantle cell lymphoma: autologous hematopoietic stem cell transplantation, allogeneic transplantation, and in more recent years, chimeric antigen receptor (CAR) T-cell therapies. Hamadani believes it is an exciting time for the treatment and management of mantle cell lymphoma, with an increasing number of cellular therapy options becoming available.
The impact of targeted treatment and immunotherapies on the role of hematopoietic stem cell transplantation in the treatment of blood cancers
Hematopoietic stem cell transplantation (HSCT) has been used for the treatment of different types of blood...
Lymphoma and COVID-19: Management guidelines
Throughout the COVID-19 pandemic, healthcare has faced a myriad of challenges, including restrictions on cancer therapies and other medical resources.
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox